Extendicare Inc. (EXETF)
OTCMKTS · Delayed Price · Currency is USD
9.66
+0.22 (2.30%)
Sep 15, 2025, 3:12 PM EDT
Extendicare Market Cap
Extendicare has a market cap or net worth of $808.18 million as of September 16, 2025. Its market cap has increased by 50.48% in one year.
Market Cap
808.18M
Enterprise Value
961.40M
Revenue
1.11B
Ranking
n/a
PE Ratio
13.25
Stock Price
$9.66
Market Cap Chart
Since May 15, 1997, Extendicare's market cap has decreased from 973.52M to 808.18M, a decrease of -16.98%. That is a compound annual growth rate of -0.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 803.16M | 30.25% |
| Dec 31, 2024 | 616.65M | 33.95% |
| Dec 29, 2023 | 460.35M | 11.06% |
| Dec 30, 2022 | 414.49M | -19.77% |
| Dec 31, 2021 | 516.64M | 10.73% |
| Dec 31, 2020 | 466.60M | -19.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |